Literature DB >> 8648231

Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia.

A P Hopperus Buma1, P P van Thiel, H O Lobel, C Ohrt, E J van Ameijden, R L Veltink, D C Tendeloo, T van Gool, M D Green, G D Todd, D E Kyle, P A Kager.   

Abstract

Three Dutch marine battalions (n=2289) serving in Western Cambodia during 1992-1993 used mefloquine as weekly malaria chemoprophylaxis. One battalion started with a loading dose. Full compliance with prophylaxis was reported by 86.3%, and possible mefloquine-related adverse events were reported by 30.2%. Sixty-four periods of malaria were diagnosed in 59 marines. During deployment, 31 Plasmodium falciparum and no Plasmodium vivax infections occurred. After return, there were 11 cases of falciparum malaria and 22 of vivax malaria, 16-72 days and 30-540 days, respectively, after stopping prophylaxis. Mefloquine-resistant parasites were isolated from 4 Dutch and 4 Khmer patients. Long-term mefloquine prophylaxis was well tolerated but not totally effective.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648231     DOI: 10.1093/infdis/173.6.1506

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Compliance with antimalarial chemoprophylaxis in German soldiers: a 6-year survey.

Authors:  H Frickmann; N G Schwarz; H-U Holtherm; W Maassen; F Vorderwülbecke; K Erkens; M Fischer; T Morwinsky; R M Hagen
Journal:  Infection       Date:  2013-01-31       Impact factor: 3.553

Review 2.  Antimalarial chemoprophylaxis in infants and children.

Authors:  M H Kramer; H O Lobel
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Adherence to malaria prophylaxis among Peace Corps Volunteers in the Africa region, 2013.

Authors:  Keren Z Landman; Kathrine R Tan; Paul M Arguin
Journal:  Travel Med Infect Dis       Date:  2014-12-11       Impact factor: 6.211

4.  Plasmodium falciparum infection during suppressive prophylaxis with mefloquine does not induce an antibody response to merozoite surface protein-1(42).

Authors:  James E Moon; Gregory A Deye; Lori Miller; Susan Fracisco; R Scott Miller; Donna Tosh; James F Cummings; Colin Ohrt; Alan J Magill
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

Review 5.  Modern malaria chemoprophylaxis.

Authors:  G Dennis Shanks; Michael D Edstein
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Artemisinin-resistant Plasmodium falciparum parasites exhibit altered patterns of development in infected erythrocytes.

Authors:  Amanda Hott; Debora Casandra; Kansas N Sparks; Lindsay C Morton; Geocel-Grace Castanares; Amanda Rutter; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

Review 7.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 8.  Mefloquine for preventing malaria during travel to endemic areas.

Authors:  Maya Tickell-Painter; Nicola Maayan; Rachel Saunders; Cheryl Pace; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

9.  Cryogenically preserved RBCs support gametocytogenesis of Plasmodium falciparum in vitro and gametogenesis in mosquitoes.

Authors:  Ashutosh K Pathak; Justine C Shiau; Matthew B Thomas; Courtney C Murdock
Journal:  Malar J       Date:  2018-12-06       Impact factor: 2.979

Review 10.  Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force.

Authors:  Stuart McCarthy
Journal:  J Parasitol Res       Date:  2015-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.